Nirmala Pandeya1, Catherine M Olsen2, David C Whiteman2. 1. QIMR Berghofer Medical Research Institute, Brisbane, QLD david.whiteman@qimrberghofer.edu.au. 2. QIMR Berghofer Medical Research Institute, Brisbane, QLD.
Abstract
OBJECTIVES: To assess the incidence and multiplicity of keratinocyte cancers (basal cell carcinoma [BCC] and squamous cell carcinoma [SCC]) excised in Australia, and to examine variations by age, sex, state, and prior skin cancer history. DESIGN: Analysis of individual-level Medicare data for keratinocyte cancer treatments (identified by eight specific MBS item codes) during 2011-2014. Histological data from the QSkin prospective cohort study were analysed to estimate BCC and SCC incidence. SETTING: A 10% systematic random sample of all people registered with Medicare during 1997-2014. PARTICIPANTS: People aged at least 20 years in 2011 who made at least one claim for any MBS medical service during 2011-2014 (1 704 193 individuals). MAIN OUTCOME MEASURES: Age-standardised incidence rates (ASRs) and standardised incidence ratios (SIRs). RESULTS: The person-based incidence of keratinocyte cancer excisions in Australia was 1531 per 100 000 person-years; incidence increased with age, and was higher for men than women (SIR, 1.43; 95% CI, 1.42-1.45). Lesion-based incidence was 3154 per 100 000 person-years. The estimated ASRs for BCC and SCC were 770 per 100 000 and 270 per 100 000 person-years respectively. During 2011-2014, 3.9% of Australians had one keratinocyte cancer excised, 2.7% had more than one excised; 74% of skin cancers were excised from patients who had two or more lesions removed. Multiplicity was strongly correlated with age; most male patients over 70 were treated for multiple lesions. Keratinocyte cancer incidence was eight times as high among people with a prior history of excisions as among those without. CONCLUSIONS: The incidence and multiplicity of keratinocyte cancer in Australia are very high, causing a large disease burden that has not previously been quantified.
OBJECTIVES: To assess the incidence and multiplicity of keratinocyte cancers (basal cell carcinoma [BCC] and squamous cell carcinoma [SCC]) excised in Australia, and to examine variations by age, sex, state, and prior skin cancer history. DESIGN: Analysis of individual-level Medicare data for keratinocyte cancer treatments (identified by eight specific MBS item codes) during 2011-2014. Histological data from the QSkin prospective cohort study were analysed to estimate BCC and SCC incidence. SETTING: A 10% systematic random sample of all people registered with Medicare during 1997-2014. PARTICIPANTS: People aged at least 20 years in 2011 who made at least one claim for any MBS medical service during 2011-2014 (1 704 193 individuals). MAIN OUTCOME MEASURES: Age-standardised incidence rates (ASRs) and standardised incidence ratios (SIRs). RESULTS: The person-based incidence of keratinocyte cancer excisions in Australia was 1531 per 100 000 person-years; incidence increased with age, and was higher for men than women (SIR, 1.43; 95% CI, 1.42-1.45). Lesion-based incidence was 3154 per 100 000 person-years. The estimated ASRs for BCC and SCC were 770 per 100 000 and 270 per 100 000 person-years respectively. During 2011-2014, 3.9% of Australians had one keratinocyte cancer excised, 2.7% had more than one excised; 74% of skin cancers were excised from patients who had two or more lesions removed. Multiplicity was strongly correlated with age; most male patients over 70 were treated for multiple lesions. Keratinocyte cancer incidence was eight times as high among people with a prior history of excisions as among those without. CONCLUSIONS: The incidence and multiplicity of keratinocyte cancer in Australia are very high, causing a large disease burden that has not previously been quantified.
Entities:
Keywords:
Neoplasms, epidemiology; Population characteristics; Population health; Skin neoplasms
Authors: Louisa G Gordon; Astrid J Rodriguez-Acevedo; Brian Køster; Gery P Guy; Craig Sinclair; Emilie Van Deventer; Adèle C Green Journal: JAMA Dermatol Date: 2020-04-01 Impact factor: 10.282
Authors: Zoë C Venables; Philippe Autier; Tamar Nijsten; Kwok F Wong; Sinéad M Langan; Brian Rous; John Broggio; Catherine Harwood; Katherine Henson; Charlotte M Proby; Jem Rashbass; Irene M Leigh Journal: JAMA Dermatol Date: 2019-03-01 Impact factor: 10.282
Authors: A Stang; L Khil; H Kajüter; N Pandeya; C D Schmults; E S Ruiz; P S Karia; A C Green Journal: J Eur Acad Dermatol Venereol Date: 2019-12 Impact factor: 6.166
Authors: Agnes Kolmodin; Nirmala P Pandeya; Catherine M Olsen; Jean Claude Dusingize; David C Whiteman; Magdalena Claeson Journal: Acta Derm Venereol Date: 2021-06-02 Impact factor: 3.875
Authors: Louisa Gordon; Catherine Olsen; David C Whiteman; Thomas M Elliott; Monika Janda; Adele Green Journal: BMJ Open Date: 2020-02-26 Impact factor: 2.692
Authors: Z C Venables; T Nijsten; K F Wong; P Autier; J Broggio; A Deas; C A Harwood; L M Hollestein; S M Langan; E Morgan; C M Proby; J Rashbass; I M Leigh Journal: Br J Dermatol Date: 2019-05-06 Impact factor: 9.302
Authors: Upekha E Liyanage; Matthew H Law; Xikun Han; Jiyuan An; Jue-Sheng Ong; Puya Gharahkhani; Scott Gordon; Rachel E Neale; Catherine M Olsen; Stuart MacGregor; David C Whiteman Journal: Hum Mol Genet Date: 2019-09-15 Impact factor: 6.150
Authors: Caradee Y Wright; D Jean du Preez; Danielle A Millar; Mary Norval Journal: Int J Environ Res Public Health Date: 2020-02-06 Impact factor: 3.390